Cargando…
Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing d...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312113/ https://www.ncbi.nlm.nih.gov/pubmed/32583053 http://dx.doi.org/10.1007/s00415-020-10001-7 |
_version_ | 1783549659868823552 |
---|---|
author | Princiotta Cariddi, Lucia Tabaee Damavandi, Payam Carimati, Federico Banfi, Paola Clemenzi, Alessandro Marelli, Margherita Giorgianni, Andrea Vinacci, Gabriele Mauri, Marco Versino, Maurizio |
author_facet | Princiotta Cariddi, Lucia Tabaee Damavandi, Payam Carimati, Federico Banfi, Paola Clemenzi, Alessandro Marelli, Margherita Giorgianni, Andrea Vinacci, Gabriele Mauri, Marco Versino, Maurizio |
author_sort | Princiotta Cariddi, Lucia |
collection | PubMed |
description | Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described yet. Herein, we report a case of a 64-year old woman with COVID19 infection who developed a PRES, and we suggest that it could be explained by the disruption of the blood brain barrier induced by the cerebrovascular endothelial dysfunction caused by SARS-CoV-2. |
format | Online Article Text |
id | pubmed-7312113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73121132020-06-24 Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient Princiotta Cariddi, Lucia Tabaee Damavandi, Payam Carimati, Federico Banfi, Paola Clemenzi, Alessandro Marelli, Margherita Giorgianni, Andrea Vinacci, Gabriele Mauri, Marco Versino, Maurizio J Neurol Letter to the Editors Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described yet. Herein, we report a case of a 64-year old woman with COVID19 infection who developed a PRES, and we suggest that it could be explained by the disruption of the blood brain barrier induced by the cerebrovascular endothelial dysfunction caused by SARS-CoV-2. Springer Berlin Heidelberg 2020-06-24 2020 /pmc/articles/PMC7312113/ /pubmed/32583053 http://dx.doi.org/10.1007/s00415-020-10001-7 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editors Princiotta Cariddi, Lucia Tabaee Damavandi, Payam Carimati, Federico Banfi, Paola Clemenzi, Alessandro Marelli, Margherita Giorgianni, Andrea Vinacci, Gabriele Mauri, Marco Versino, Maurizio Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient |
title | Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient |
title_full | Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient |
title_fullStr | Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient |
title_full_unstemmed | Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient |
title_short | Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient |
title_sort | reversible encephalopathy syndrome (pres) in a covid-19 patient |
topic | Letter to the Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312113/ https://www.ncbi.nlm.nih.gov/pubmed/32583053 http://dx.doi.org/10.1007/s00415-020-10001-7 |
work_keys_str_mv | AT princiottacariddilucia reversibleencephalopathysyndromepresinacovid19patient AT tabaeedamavandipayam reversibleencephalopathysyndromepresinacovid19patient AT carimatifederico reversibleencephalopathysyndromepresinacovid19patient AT banfipaola reversibleencephalopathysyndromepresinacovid19patient AT clemenzialessandro reversibleencephalopathysyndromepresinacovid19patient AT marellimargherita reversibleencephalopathysyndromepresinacovid19patient AT giorgianniandrea reversibleencephalopathysyndromepresinacovid19patient AT vinaccigabriele reversibleencephalopathysyndromepresinacovid19patient AT maurimarco reversibleencephalopathysyndromepresinacovid19patient AT versinomaurizio reversibleencephalopathysyndromepresinacovid19patient |